J R Soc Med 2004;97:511-520
doi:10.1258/jrsm.97.11.511
© 2004 Royal Society of Medicine
Metabolic syndrome: maladaptation to a modern world
Terence J Wilkin MD FRCP
Linda D Voss PhD
Department of Endocrinology & Metabolism, Peninsula Medical School
(Plymouth campus), Level 7, Derriford Hospital, Plymouth PL6 8DH, UK

View larger version (15K):
[in a new window]
|
Figure 1. The shift in distribution of BMI of UK adults between the 1970s (black)
and the 1990s (open).
Both the median and the mean have moved, suggesting that the whole of
society is involved. Modified from ref.
3
|
|

View larger version (13K):
[in a new window]
|
Figure 2. Schematic representation of the feedback loop controlling blood
glucose.
If the islets fail (type 1 diabetes), glucose rises because insulin falls.
If the tissues fail (type 2 diabetes), insulin rises because glucose rises
|
|

View larger version (17K):
[in a new window]
|
Figure 3. The metabolic wheel. Insulin resistance at its centre simultaneously
drives a number of metabolic processes. The spokes are each linked through the
hub, rather than to each other. PAI-1=plasminogen activator inhibitor 1;
PCV=haematocrit
|
|

View larger version (105K):
[in a new window]
|
Figure 4. A transverse abdominal CT scan showing intraabdominal visceral fat in
black (area 13459 mm2, metabolically harmful) but, in addition, a
substantial amount of subcutaneous fat (area 5823 mm2,
metabolically harmless)
|
|

View larger version (13K):
[in a new window]
|
Figure 5. The relationship between visceral adiposity (% central abdominal fat),
BMI and insulin resistance. BMI does not inform on fat distribution and is
a poor proxy for insulin resistance (After Ref.
47)
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?